Next Article in Journal
ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma
Next Article in Special Issue
Parathyroid Hormone (PTH) Increases Skeletal Tumour Growth and Alters Tumour Distribution in an In Vivo Model of Breast Cancer
Previous Article in Journal
Tapetal-Delayed Programmed Cell Death (PCD) and Oxidative Stress-Induced Male Sterility of Aegilops uniaristata Cytoplasm in Wheat
Previous Article in Special Issue
Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity
Open AccessReview

Cellular and Molecular Mediators of Bone Metastatic Lesions

Bone Physiopathology Group, Multifactorial Disease and Complex Phenotype Research Area, Bambino Gesù Children’s Hospital, 00146 Rome, Italy
Department of Radiotherapy, Policlinico Umberto I, Sapienza University of Rome, 00146 Rome, Italy
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(6), 1709;
Received: 7 May 2018 / Revised: 1 June 2018 / Accepted: 6 June 2018 / Published: 8 June 2018
(This article belongs to the Special Issue Bone Metastasis: Pathophysiology and Molecular Mechanisms)
Bone is the preferential site of metastasis for breast and prostate tumor. Cancer cells establish a tight relationship with the host tissue, secreting factors that stimulate or inhibit bone cells, receiving signals generated from the bone remodeling activity, and displaying some features of bone cells. This interplay between tumor and bone cells alters the physiological bone remodeling, leading to the generation of a vicious cycle that promotes bone metastasis growth. To prevent the skeletal-related events (SRE) associated with bone metastasis, approaches to inhibit osteoclast bone resorption are reported. The bisphosphonates and Denosumab are currently used in the treatment of patients affected by bone lesions. They act to prevent or counteract the SRE, including pathologic fractures, spinal cord compression, and pain associated with bone metastasis. However, their primary effects on tumor cells still remain controversial. In this review, a description of the mechanisms leading to the onset of bone metastasis and clinical approaches to treat them are described. View Full-Text
Keywords: bone metastasis; osteoclast; osteoblast bone metastasis; osteoclast; osteoblast
Show Figures

Graphical abstract

MDPI and ACS Style

Battafarano, G.; Rossi, M.; Marampon, F.; Del Fattore, A. Cellular and Molecular Mediators of Bone Metastatic Lesions. Int. J. Mol. Sci. 2018, 19, 1709.

AMA Style

Battafarano G, Rossi M, Marampon F, Del Fattore A. Cellular and Molecular Mediators of Bone Metastatic Lesions. International Journal of Molecular Sciences. 2018; 19(6):1709.

Chicago/Turabian Style

Battafarano, Giulia; Rossi, Michela; Marampon, Francesco; Del Fattore, Andrea. 2018. "Cellular and Molecular Mediators of Bone Metastatic Lesions" Int. J. Mol. Sci. 19, no. 6: 1709.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop